Precision BioSearch supports Maxion Therapeutics to appoint Joel Edwards as CBO
Precision BioSearch supports Maxion Therapeutics to appoint Joel Edwards as CBO
AdvanCell partners with Precision BioSearch to appoint VP, Global Head of Quality
Precision BioSearch is pleased to announce its partnership with AdvanCell, a global leader in radioligand therapy, to appoint Eugene Borelli as VP, Global Head of Quality.
Precision BioSearch Celebrates Fifth Anniversary during London Life Sciences Week
Precision BioSearch is pleased to announce the celebration of its fifth anniversary and the hosting of a CEO and Investor event on 19th November 2025.
Malcolm Silander stands for Election to BIA Board of Directors
Malcolm Silander, Co-founder of Precision BioSearch, has announced his candidacy for election to the Board of Directors of the BioIndustry Association (BIA), the UK’s leading trade association for innovative life sciences and biotech companies.
Malcolm Silander participates in a roundtable on ‘Building High-Performing Teams’
taking place on 18–19 June 2025 at ExCel London. The session, titled “Building High-Performing Teams and Strategic Connections,”
Precision BioSearch expands team with appointment of Head of Research & Operations
Natalie joins from Odgers Berndtson, a blue-chip executive search firm, where she spent over a decade in the Life Sciences practice.
Precision BioSearch, corporate sponsors of Bioequity Europe 2025
Precision BioSearch is proud to sponsor Bio€quity Europe for the third consecutive year. This year’s event will take place from May 12-14, 2025, in the historic city of Bruges, Belgium.
International Day of Women and Girls in Science – Her Voice in Science
To celebrate the 2025 International Day of Women and Girls in Science, we have followed the “Her Voice in Science” theme and invited Nebu~Flow CEO Andrea Cusack to share her insights on gender influence in the Life Sciences sector.
Optieum Biotechnologies partners with Precision BioSearch to appoint CSO
Precision BioSearch was delighted to partner with Optieum Biotechnologies Inc. (“Optieum”), a biotechnology company focused on discovering and developing innovative CAR-T cell therapies, to secure the appointment of Dr. Dan MacLeod as Chief Scientific Officer.
Malcolm Silander is invited to Chair a panel session at LSX World Congress 2024
Malcolm Silander, Co-founder of Precision BioSearch, was delighted to be invited to Chair a panel session at LSX – Partnering for Life Science Executives World Congress, held on 29th-30th May 2024 in London, UK.